Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
Research
[키워드] acute respiratory syndrome
adjust
age
antibody
Biweekly
calculated
change
Clinical management
conducted
coronavirus
cross-sectional
detectable
District
estimate
Estimated
estimates
Evidence
exposure
finding
groups
helping
immunoassays
Importance
individual
infected with SARS-CoV-2
Infection
infections
Laboratory
less
measure
objective
Older
over
participant
Point
presence of antibody
Prevalence
proportion
provided
ranged
regions
Relevance
repeated
Result
Sample
SARS-CoV-2
SARS-CoV-2 antibodies
SARS-CoV-2 antibody
SARS-COV-2 infection
sera
Seroprevalence
seroprevalence survey
serum
serum sample
setting
Sex
specimen
specimens
Spread
submitted
Surveillance
tested
was used
while
women
[DOI] 10.1001/jamainternmed.2020.7976 PMC 바로가기 [Article Type] Research
[DOI] 10.1001/jamainternmed.2020.7976 PMC 바로가기 [Article Type] Research